XML 107 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Financial Instruments
6 Months Ended
Jun. 30, 2013
Derivative Financial Instruments [Abstract]  
Derivative Financial Instruments
Note 16.  Derivative Financial Instruments
The Company is exposed to certain risks related to its ongoing business operations. The primary risk managed by using derivative instruments is foreign currency risk.  From time to time the Company’s foreign subsidiaries enter into foreign currency exchange contracts to mitigate exposure to fluctuations in currency exchange rates.  The fair value of the derivative financial instrument is recorded on the Company’s balance sheet and is adjusted to fair value at each measurement date.  The changes in fair value are recognized in the consolidated statements of income in the current period.  The Company does not engage in speculative transactions nor does it hold or issue financial instruments for trading purposes.  The average U.S. dollar equivalent notional amount of outstanding foreign currency exchange contracts was $12,041,000 during the six-month period ended June 30, 2013. The Company reported $1,001,000 of derivative assets in short-term investments at June 30, 2013.  At December 31, 2012, the Company reported $145,000 of derivative liabilities in other accrued liabilities.  The Company recognized, as a component of cost of sales, a net gain on the change in fair value of derivative financial instruments of $939,000 in the three-month period ended June 30, 2013. In the three-months ended June 30, 2012, the Company recognized as a component of cost of sales, a net loss of $77,000.  For the six-month period ended June 30, 2013, the Company recognized, as a component of cost of sales, a net gain of $1,276,000.  In the six-months ended June 30, 2012, the Company recognized, as a component of cost of sales, a net loss of $401,000.  There were no derivatives that were designated as hedges at June 30, 2013.